DocGo (DCGO) vs GeneDx (WGS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
GeneDx (WGS) has outperformed DocGo (DCGO) over the past year, losing 44.8% versus a loss of 73.1%. Over five years, WGS leads with a -73.7% price change compared with -96.6% for DCGO. GeneDx is the larger company by market cap ($2.02 billion vs $33.5 million), about 60.2 times the size.
On valuation, DocGo trades at a lower forward P/E (8.7x vs 56.5x for GeneDx).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DCGO | WGS |
|---|---|---|
| Share price | $0.3387 | $67.73 |
| Market cap | $33.53M | $2.02B |
| 1-day change | -1.83% | -1.17% |
| YTD return | -61.42% | -47.92% |
| 1-year return | -73.12% | -44.80% |
| 5-year return | -96.61% | -73.65% |
| Forward P/E | 8.73 | 56.51 |
| EPS (TTM) | $-1.94 | $-3.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.65 | $170.87 |
| 52-week low | $0.311 | $32.21 |
| Distance from 52-week high | -79.47% | -60.36% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +455.06% | +38.05% |
| Average volume | 722.71K | 730.21K |
| Shares outstanding | 98.99M | 29.82M |
| Employees | 2,537 | 1,300 |
| Sector | Healthcare | Health Care |
| Industry | Medical Care Facilities | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GeneDx is about 60.2 times larger than DocGo by market value ($2.02B vs $33.53M).
- WGS has outperformed DCGO by 28.3 percentage points over the past year.
- The two companies sit in different sectors: DocGo in Healthcare and GeneDx in Health Care.
About DocGo
DCGO stock →DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom.
Healthcare · Medical Care Facilities · 2,537 employees
About GeneDx
WGS stock →GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Health Care · Medical/Nursing Services · 1,300 employees
DCGO vs WGS FAQ
Which is bigger, DocGo or GeneDx?
GeneDx (WGS) is larger, with a market capitalization of $2.02B compared with $33.53M for DocGo (DCGO).
Which stock has performed better over the past year, DCGO or WGS?
WGS returned -44.80% over the past 12 months, compared with -73.12% for DCGO (price return, excluding dividends). Past performance does not predict future results.
Are DocGo and GeneDx in the same industry?
No. DocGo is in the Healthcare sector, while GeneDx is in Health Care.